Tanuja Chitnis

Determining the optimal treatment strategy in MS 4:18
Determining the optimal treatment strategy in MS
Tanuja Chitnis • 23 Feb 2021
Determining the optimal treatment strategy in MS 4:18
Determining the optimal treatment strategy in MS
Tanuja Chitnis • 23 Feb 2021
Changing approaches to cognitive assessment in MS 1:37
Changing approaches to cognitive assessment in MS
Tanuja Chitnis • 23 Feb 2021
Ensemble learning methods predict disease course in MS 2:26
Ensemble learning methods predict disease course in MS
Tanuja Chitnis • 23 Feb 2021
Serum neurofilament levels are associated with health outcomes and resource use in MS 1:34
Serum neurofilament levels are associated with health outcomes and resource use in MS
Tanuja Chitnis • 23 Feb 2021
MS disease stage modulates the relationship between serum neurofilament light and age 1:45
MS disease stage modulates the relationship between serum neurofilament light and age
Tanuja Chitnis • 23 Feb 2021
Emerging research in pediatric MS 1:26
Emerging research in pediatric MS
Tanuja Chitnis • 24 May 2020
Pediatric MS: where does research need to move? 1:08
Pediatric MS: where does research need to move?
Tanuja Chitnis • 24 May 2020
Pediatric versus adult multiple sclerosis 1:24
Pediatric versus adult multiple sclerosis
Tanuja Chitnis • 24 May 2020
TERIKIDS study: teriflunomide in pediatric patients with relapsing MS 2:12
TERIKIDS study: teriflunomide in pediatric patients with relapsing MS
Tanuja Chitnis • 24 May 2020
The content of VJNeurology is intended for healthcare professionals